Cover Image
市場調查報告書

數位治療學的全球市場預測 2021年:前糖尿病預防、肥胖預防、糖尿病治療、CVD治療、戒煙治療

Digital Therapeutics Market by Application (Prevention (Prediabetes, Obesity), Care (Diabetes, CVD, CNS, CRD, Smoking Cessation, Musculoskeletal)), Sales Channel (B2C, B2B) - Global Forecast to 2021

出版商 MarketsandMarkets 商品編碼 362140
出版日期 內容資訊 英文 191 Pages
訂單完成後即時交付
價格
Back to Top
數位治療學的全球市場預測 2021年:前糖尿病預防、肥胖預防、糖尿病治療、CVD治療、戒煙治療 Digital Therapeutics Market by Application (Prevention (Prediabetes, Obesity), Care (Diabetes, CVD, CNS, CRD, Smoking Cessation, Musculoskeletal)), Sales Channel (B2C, B2B) - Global Forecast to 2021
出版日期: 2016年07月01日 內容資訊: 英文 191 Pages
簡介

數位治療學市場規模,預計從2016年到2021年以27.7%的年複合成長率發展,從2016年的1億1,000萬美元到2021年達到4億5,790萬美元。

本報告提供全球數位治療學市場調查,市場概要,供應鏈,市場成長的各種影響因素及市場機會分析,應用,銷售管道,及各地區/主要國家趨勢與市場規模的變化與預測,競爭環境,以及主要企業的簡介等彙整。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 數位治療學市場概要
  • 數位治療學市場:各應用領域
  • 預防應用數位治療學市場
  • 治療/照護應用數位治療學市場
  • 數位治療學市場:銷售管道
  • B2C銷售管道數位治療學市場:各購買者
  • B2C銷售管道數位治療學市場:各購買者
  • 數位治療學市場:地區概要

第5章 市場概要

  • 簡介
  • 市場動態
    • 成長推進因素
    • 阻礙成長要素
    • 市場機會
    • 市場課題

第6章 產業趨勢

  • 供應鏈分析
  • 波特的五力分析
  • 法規必要條件
  • 創業投資投資
  • 開發中產品

第7章 數位治療學市場:各銷售管道

  • 簡介
  • B2C
    • 看護者
    • 患者
  • B2B
    • 供應商
    • 保險者
    • 醫藥品企業
    • 雇主
    • 其他購買者

第8章 數位治療學市場:各應用領域

  • 簡介
  • 預防應用
    • 前糖尿病
    • 肥胖
  • 治療/照護相關應用
    • 糖尿病
    • 中樞神經系統 (CNS) 疾病
    • 慢性呼吸疾病 (CRD)
    • 肌肉骨骼障礙
    • 心血管疾病
    • 戒煙
    • 服藥醫囑遵從性
    • 其他的用途

第9章 數位治療學市場:各地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 其他的歐洲 (ROE)
  • 亞太地區 (APAC)
  • 其他 (RoW)

第10章 競爭情形

  • 概要
  • 競爭情形、趨勢

第11章 企業簡介

  • 簡介
  • PROTEUS DIGITAL HEALTH, INC.
  • OMADA HEALTH, INC.
  • WELLDOC, INC.
  • LIVONGO HEALTH
  • NOOM INC.
  • GINGER.IO, INC.
  • PROPELLER HEALTH
  • 2MORROW INC.
  • CANARY HEALTH INC.
  • MANGO HEALTH INC.

第12章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: HIT 4407

The digital therapeutics market in terms of value is expected to reach USD 457.9 million by 2021 from USD 110 million in 2016, growing at a CAGR of 27.7% from 2016 to 2021. This market is categorized on the basis of application, sales channel, and region.

Major factors contributing to the growth of the digital therapeutics market include increasing incidence of chronic diseases, rising focus on preventive healthcare, technological advancements, growing need to control healthcare costs, significant increase in venture capital investments, and the benefits of digital therapeutics. Government initiatives to support the development and adoption of digital therapeutics solutions also provide an impetus for the growth of this market. For instance, in 2010, the U.S. Congress authorized the Centers for Disease Control and Prevention (CDC) to create the Diabetes Prevention Recognition Program (DPRP) and recognize programs that meet evidence-based standards provided by DPRP. This includes programs such as the "Prevent" program offered by Omada Health Inc. (U.S.) implemented for the prevention of diabetes. Additionally, the Affordable Care Act (2010) authorized a series of diabetes prevention programs under the National Diabetes Prevention Program (NDPP). One example of such a program is three digital diabetes prevention programs, provided by Canary Health (U.S.), Noom Health (U.S.), and Omada Health (U.S.), which received recognition in 2015. Such government initiatives are likely to provide an impetus for market growth. Relatively untapped markets in developing regions of Asia-Pacific and unexplored therapeutic applications have opened an array of opportunities for the digital therapeutics market. However, factors such as a lack of awareness and access to digital therapeutics programs in developing countries, patient data privacy concerns, and resistance from traditional healthcare providers may restrain the growth of this market.

Apart from the comprehensive geographical and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise basic views on key players in the digital therapeutics market and their product portfolios, developments, and strategies. The above-mentioned market research data, current market size, and forecast of the future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, changes in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms garner a greater market share. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of top players in the digital therapeutics market. The report analyzes the digital therapeutics market by application, sales channel, and region
  • Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the digital therapeutics market
  • Competitive Assessment: In-depth assessment of market strategies, geographical and business segments, and product portfolios of leading players in the digital therapeutics market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various digital therapeutics products across geographies
  • Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the digital therapeutics market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. MARKET STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. MARKET SIZE ESTIMATION
  • 2.2. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.3. KEY DATA FROM SECONDARY SOURCES
  • 2.4. KEY DATA FROM PRIMARY SOURCES
  • 2.5. KEY INDUSTRY INSIGHTS
  • 2.6. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. DIGITAL THERAPEUTICS MARKET OVERVIEW
  • 4.2. DIGITAL THERAPEUTICS MARKET, BY APPLICATION
  • 4.3. DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS
  • 4.4. DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE APPLICATIONS
  • 4.5. DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL
  • 4.6. DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER
  • 4.7. DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER
  • 4.8. DIGITAL THERAPEUTICS MARKET: GEOGRAPHIC SNAPSHOT

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Increasing incidence of preventable chronic diseases
      • 5.2.1.2. Rising focus on preventive healthcare
      • 5.2.1.3. Technological advancements
      • 5.2.1.4. Need to control healthcare costs
      • 5.2.1.5. Significant increase in venture capital investments
      • 5.2.1.6. Benefits offered by digital therapeutics
        • 5.2.1.6.1. Ability to induce behavioral change
        • 5.2.1.6.2. Improved drug adherence
        • 5.2.1.6.3. Patient convenience and user-friendliness
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Lack of awareness and access to digital therapeutics programs in developing countries
      • 5.2.2.2. Patient data privacy concerns
      • 5.2.2.3. Resistance from traditional healthcare providers
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Emerging markets offer significant growth opportunities
      • 5.2.3.2. Large undiagnosed and untreated population
      • 5.2.3.3. Unexplored therapeutic applications
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Unfavorable payment models
      • 5.2.4.2. Stringent regulatory guidelines
      • 5.2.4.3. Reluctance among patients to adopt digital therapeutics

6. INDUSTRY INSIGHTS

  • 6.1. INTRODUCTION
  • 6.2. PORTER'S FIVE FORCES ANALYSIS
    • 6.2.1. THREAT OF NEW ENTRANTS
    • 6.2.2. BARGAINING POWER OF SUPPLIERS
    • 6.2.3. BARGAINING POWER OF BUYERS
    • 6.2.4. THREAT OF SUBSTITUTES
    • 6.2.5. INTENSITY OF COMPETITIVE RIVALRY
  • 6.3. REGULATORY REQUIREMENTS
    • 6.3.1. EMERGING REGULATORY FRAMEWORK FOR DIGITAL THERAPEUTICS
    • 6.3.2. HEALTH INFORMATION PORTABILITY AND ACCOUNTABILITY ACT (HIPAA)
  • 6.4. VENTURE CAPITAL INVESTMENTS
  • 6.5. PIPELINE PRODUCTS

7. DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL

  • 7.1. INTRODUCTION
  • 7.2. B2C
    • 7.2.1. CAREGIVERS
    • 7.2.2. PATIENTS
  • 7.3. B2B
    • 7.3.1. PROVIDERS
    • 7.3.2. PAYERS
    • 7.3.3. PHARMACEUTICAL COMPANIES
    • 7.3.4. EMPLOYERS
    • 7.3.5. OTHER BUYERS

8. DIGITAL THERAPEUTICS MARKET, BY TYPE OF APPLICATION

  • 8.1. INTRODUCTION
  • 8.2. PREVENTIVE APPLICATIONS
    • 8.2.1. PREDIABETES
    • 8.2.2. OBESITY
  • 8.3. TREATMENT/CARE-RELATED APPLICATIONS
    • 8.3.1. DIABETES
    • 8.3.2. CENTRAL NERVOUS SYSTEM (CNS) DISORDERS
    • 8.3.3. CHRONIC RESPIRATORY DISEASES (CRD)
    • 8.3.4. MUSCULOSKELETAL DISORDERS
    • 8.3.5. CARDIOVASCULAR DISEASES
    • 8.3.6. SMOKING CESSATION
    • 8.3.7. MEDICATION ADHERENCE
    • 8.3.8. OTHER APPLICATIONS

9. DIGITAL THERAPEUTICS MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. U.S.
    • 9.2.2. CANADA
  • 9.3. EUROPE
    • 9.3.1. GERMANY
    • 9.3.2. U.K.
    • 9.3.3. FRANCE
    • 9.3.4. SPAIN
    • 9.3.5. REST OF EUROPE (ROE)
  • 9.4. ASIA-PACIFIC (APAC)
  • 9.5. REST OF THE WORLD (ROW)

10. COMPETITIVE LANDSCAPE

  • 10.1. OVERVIEW
  • 10.2. COMPETITIVE SITUATIONS AND TRENDS
    • 10.2.1. PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS
    • 10.2.2. INVESTMENTS
    • 10.2.3. NEW PRODUCT LAUNCHES
    • 10.2.4. OTHER STRATEGIES

11. COMPANY PROFILES (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

  • 11.1. INTRODUCTION
  • 11.2. PROTEUS DIGITAL HEALTH, INC.
  • 11.3. OMADA HEALTH, INC.
  • 11.4. WELLDOC, INC.
  • 11.5. LIVONGO HEALTH
  • 11.6. NOOM INC.
  • 11.7. GINGER.IO, INC.
  • 11.8. PROPELLER HEALTH
  • 11.9. 2MORROW INC.
  • 11.10. CANARY HEALTH INC.
  • 11.11. MANGO HEALTH INC.
  • 11.12. CLICK THERAPEUTICS, INC.*
  • 11.13. PEAR THERAPEUTICS, INC.*
  • 11.14. AKILI INTERACTIVE LABS, INC.*
  • 11.15. WELLTHY THERAPEUTICS PVT. LTD*

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. INSIGHTS FROM INDUSTRY EXPERTS
  • 12.2. DISCUSSION GUIDE
  • 12.3. OTHER DEVELOPMENTS, BY COMPANY, 2013-2016
  • 12.4. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.5. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 12.6. AVAILABLE CUSTOMIZATIONS
  • 12.7. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: INCREASING INCIDENCE OF PREVENTABLE CHRONIC DISEASES: A MAJOR MARKET DRIVER
  • TABLE 2: LACK OF AWARENESS AND ACCESS TO DIGITAL THERAPEUTICS PROGRAMS IN DEVELOPING COUNTRIES: A MAJOR RESTRAINT FOR MARKET GROWTH
  • TABLE 3: EMERGING MARKETS OFFER SIGNIFICANT GROWTH OPPORTUNITIES
  • TABLE 4: STRINGENT REGULATORY GUIDELINES: A MAJOR CHALLENGE FOR MARKET GROWTH
  • TABLE 5: LIST OF VENTURE CAPITAL INVESTMENTS IN THE DIGITAL THERAPEUTICS MARKET (2007-2016)
  • TABLE 6: LIST OF PIPELINE PRODUCTS IN THE MARKET (2015-2021)
  • TABLE 7: DIGITAL THERAPEUTICS MARKET SIZE, BY SALES CHANNEL, 2014-2021 (USD MILLION)
  • TABLE 8: DIGITAL THERAPEUTICS MARKET SIZE FOR B2C SALES CHANNEL, BY BUYER, 2014-2021 (USD MILLION)
  • TABLE 9: DIGITAL THERAPEUTICS MARKET SIZE FOR B2C SALES CHANNEL, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 10: NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR B2C SALES CHANNEL, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 11: EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR B2C SALES CHANNEL, BY COUNTRY, 2014-2021 (USD THOUSAND)
  • TABLE 12: DIGITAL THERAPEUTICS MARKET SIZE FOR CAREGIVERS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 13: NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR CAREGIVERS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 14: EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR CAREGIVERS, BY COUNTRY, 2014-2021 (USD THOUSAND)
  • TABLE 15: DIGITAL THERAPEUTICS MARKET SIZE FOR PATIENTS, BY REGION, 2014-2021 (USD THOUSAND)
  • TABLE 16: NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR PATIENTS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 17: EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR PATIENTS, BY COUNTRY, 2014-2021 (USD THOUSAND)
  • TABLE 18: DIGITAL THERAPEUTICS MARKET SIZE FOR B2B SALES CHANNEL, BY BUYER, 2014-2021 (USD MILLION)
  • TABLE 19: DIGITAL THERAPEUTICS MARKET SIZE FOR B2B SALES CHANNEL, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 20: NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR B2B SALES CHANNEL, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 21: EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR B2B SALES CHANNEL, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 22: DIGITAL THERAPEUTICS MARKET SIZE FOR PROVIDERS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 23: NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR PROVIDERS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 24: EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR PROVIDERS, BY COUNTRY, 2014-2021 (USD THOUSAND)
  • TABLE 25: DIGITAL THERAPEUTICS MARKET SIZE FOR PAYERS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 26: NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR PAYERS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 27: EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR PAYERS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 28: DIGITAL THERAPEUTICS MARKET SIZE FOR PHARMACEUTICAL COMPANIES, BY REGION, 2014-2021 (USD THOUSAND)
  • TABLE 29: NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 30: EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2014-2021 (USD THOUSAND)
  • TABLE 31: DIGITAL THERAPEUTICS MARKET SIZE FOR EMPLOYERS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 32: NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR EMPLOYERS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 33: EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR EMPLOYERS, BY COUNTRY, 2014-2021 (USD THOUSAND)
  • TABLE 34: DIGITAL THERAPEUTICS MARKET SIZE FOR OTHER BUYERS, BY REGION, 2014-2021 (USD THOUSAND)
  • TABLE 35: NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR OTHER BUYERS, BY COUNTRY, 2014-2021 (USD THOUSAND)
  • TABLE 36: EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR OTHER BUYERS, BY COUNTRY, 2014-2021 (USD THOUSAND)
  • TABLE 37: DIGITAL THERAPEUTICS MARKET SIZE, BY TYPE OF APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 39: DIGITAL THERAPEUTICS MARKET SIZE FOR PREVENTIVE APPLICATIONS, 2014-2021 (USD MILLION)
  • TABLE 40: DIGITAL THERAPEUTICS MARKET SIZE FOR PREVENTIVE APPLICATIONS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 41: NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR PREVENTIVE APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 42: EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR PREVENTIVE APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 43: DIGITAL THERAPEUTICS MARKET SIZE FOR PREDIABETES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 44: NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR PREDIABETES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 45: EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR PREDIABETES, BY COUNTRY, 2014-2021 (USD THOUSAND)
  • TABLE 46: DIGITAL THERAPEUTICS MARKET SIZE FOR OBESITY, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 47: NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR OBESITY, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 48: EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR OBESITY, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 49: DIGITAL THERAPEUTICS MARKET SIZE FOR TREATMENT/CARE-RELATED APPLICATIONS, 2014-2021 (USD MILLION)
  • TABLE 50: DIGITAL THERAPEUTICS MARKET SIZE FOR TREATMENT/CARE-RELATED APPLICATIONS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 51: NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR TREATMENT/CARE-RELATED APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 52: EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR TREATMENT/CARE-RELATED APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 53: DIGITAL THERAPEUTICS MARKET SIZE FOR DIABETES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 54: NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR DIABETES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 55: EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR DIABETES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 56: DIGITAL THERAPEUTICS MARKET SIZE FOR CNS DISORDERS, BY REGION, 2014-2021 (USD THOUSAND)
  • TABLE 57: NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR CNS DISORDERS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 58: EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR CNS DISORDERS, BY COUNTRY, 2014-2021 (USD THOUSAND)
  • TABLE 59: DIGITAL THERAPEUTICS MARKET SIZE FOR CHRONIC RESPIRATORY DISEASES, BY REGION, 2014-2021 (USD THOUSAND)
  • TABLE 60: NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR CHRONIC RESPIRATORY DISEASES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 61: EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR CHRONIC RESPIRATORY DISEASES, BY COUNTRY, 2014-2021 (USD THOUSAND)
  • TABLE 62: DIGITAL THERAPEUTICS MARKET SIZE FOR MUSCULOSKELETAL DISORDERS, BY REGION, 2014-2021 (USD THOUSAND)
  • TABLE 63: NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR MUSCULOSKELETAL DISORDERS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 64: EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR MUSCULOSKELETAL DISORDERS, BY COUNTRY, 2014-2021 (USD THOUSAND)
  • TABLE 65: DIGITAL THERAPEUTICS MARKET SIZE FOR CARDIOVASCULAR DISEASES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 66: NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 67: EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2014-2021 (USD THOUSAND)
  • TABLE 68: DIGITAL THERAPEUTICS MARKET SIZE FOR SMOKING CESSATION, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 69: NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR SMOKING CESSATION, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 70: EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR SMOKING CESSATION, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 71: DIGITAL THERAPEUTICS MARKET SIZE FOR MEDICATION ADHERENCE, BY REGION, 2014-2021 (USD THOUSAND)
  • TABLE 72: NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR MEDICATION ADHERENCE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 73: EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR MEDICATION ADHERENCE, BY COUNTRY, 2014-2021 (USD THOUSAND)
  • TABLE 74: DIGITAL THERAPEUTICS MARKET SIZE FOR OTHER APPLICATIONS, BY REGION, 2014-2021 (USD THOUSAND)
  • TABLE 75: NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR OTHER APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 76: EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR OTHER APPLICATIONS, BY COUNTRY, 2014-2021 (USD THOUSAND)
  • TABLE 77: DIGITAL THERAPEUTICS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 78: NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 79: NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 80: NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR PREVENTIVE APPLICATIONS, BY DISORDER, 2014-2021 (USD MILLION)
  • TABLE 81: NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR TREATMENT/CARE-BASED APPLICATIONS, 2014-2021 (USD MILLION)
  • TABLE 82: NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE, BY SALES CHANNEL, 2014-2021 (USD MILLION)
  • TABLE 83: NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR B2C SALES CHANNEL, BY BUYER, 2014-2021 (USD MILLION)
  • TABLE 84: NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR B2B SALES CHANNEL, BY BUYER, 2014-2021 (USD MILLION)
  • TABLE 85: U.S.: DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 86: U.S.: DIGITAL THERAPEUTICS MARKET SIZE FOR PREVENTIVE APPLICATIONS, BY DISORDER, 2014-2021 (USD MILLION)
  • TABLE 87: U.S.: DIGITAL THERAPEUTICS MARKET SIZE FOR TREATMENT/CARE-BASED APPLICATIONS, 2014-2021 (USD MILLION)
  • TABLE 88: U.S.: DIGITAL THERAPEUTICS MARKET SIZE, BY SALES CHANNEL, 2014-2021 (USD MILLION)
  • TABLE 89: U.S.: DIGITAL THERAPEUTICS MARKET SIZE FOR B2C SALES CHANNEL, BY BUYER, 2014-2021 (USD MILLION)
  • TABLE 90: U.S.: DIGITAL THERAPEUTICS MARKET SIZE FOR B2B SALES CHANNEL, BY BUYER, 2014-2021 (USD MILLION)
  • TABLE 91: CANADA: DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 92: CANADA: DIGITAL THERAPEUTICS MARKET SIZE FOR PREVENTIVE APPLICATIONS, BY DISORDER, 2014-2021 (USD MILLION)
  • TABLE 93: CANADA: DIGITAL THERAPEUTICS MARKET SIZE FOR TREATMENT/CARE-BASED APPLICATIONS, 2014-2021 (USD MILLION)
  • TABLE 94: CANADA: DIGITAL THERAPEUTICS MARKET SIZE, BY SALES CHANNEL, 2014-2021 (USD MILLION)
  • TABLE 95: CANADA: DIGITAL THERAPEUTICS MARKET SIZE FOR B2C SALES CHANNEL, BY BUYER, 2014-2021 (USD MILLION)
  • TABLE 96: CANADA: DIGITAL THERAPEUTICS MARKET SIZE FOR B2B SALES CHANNEL, BY BUYER, 2014-2021 (USD THOUSAND)
  • TABLE 97: EUROPE: DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 98: EUROPE: DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 99: EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR PREVENTIVE APPLICATIONS, BY DISORDER, 2014-2021 (USD MILLION)
  • TABLE 10: EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR TREATMENT/CARE-BASED APPLICATIONS, 2014-2021 (USD MILLION)
  • TABLE 101: EUROPE: DIGITAL THERAPEUTICS MARKET SIZE, BY SALES CHANNEL, 2014-2021 (USD MILLION)
  • TABLE 102: EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR B2C SALES CHANNEL, BY BUYER, 2014-2021 (USD MILLION)
  • TABLE 103: EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR B2B SALES CHANNEL, BY BUYER, 2014-2021 (USD MILLION)
  • TABLE 104: GERMANY: DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 105: GERMANY: DIGITAL THERAPEUTICS MARKET SIZE FOR PREVENTIVE APPLICATIONS, BY DISORDER, 2014-2021 (USD MILLION)
  • TABLE 106: DIGITAL THERAPEUTICS MARKET SIZE FOR TREATMENT/CARE-BASED APPLICATIONS, 2014-2021 (USD MILLION)
  • TABLE 107: GERMANY: DIGITAL THERAPEUTICS MARKET SIZE, BY SALES CHANNEL, 2014-2021 (USD MILLION)
  • TABLE 108: GERMANY: DIGITAL THERAPEUTICS MARKET SIZE FOR B2C SALES CHANNEL, BY BUYER, 2014-2021 (USD MILLION)
  • TABLE 109: GERMANY: DIGITAL THERAPEUTICS MARKET SIZE FOR B2B SALES CHANNEL, BY BUYER, 2014-2021 (USD MILLION)
  • TABLE 110: U.K.: DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 111: U.K.: DIGITAL THERAPEUTICS MARKET SIZE FOR PREVENTIVE APPLICATIONS, BY DISORDER, 2014-2021 (USD MILLION)
  • TABLE 112: U.K.: DIGITAL THERAPEUTICS MARKET SIZE FOR TREATMENT/CARE-BASED APPLICATIONS, 2014-2021 (USD THOUSAND)
  • TABLE 113: U.K.: DIGITAL THERAPEUTICS MARKET SIZE, BY SALES CHANNEL, 2014-2021 (USD MILLION)
  • TABLE 114: U.K.: DIGITAL THERAPEUTICS MARKET SIZE FOR B2C SALES CHANNEL, BY BUYER, 2014-2021 (USD MILLION)
  • TABLE 115: U.K.: DIGITAL THERAPEUTICS MARKET SIZE FOR B2B SALES CHANNEL, BY BUYER, 2014-2021 (USD THOUSAND)
  • TABLE 116: FRANCE: DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 117: FRANCE: DIGITAL THERAPEUTICS MARKET SIZE FOR PREVENTIVE APPLICATIONS, BY DISORDER, 2014-2021 (USD MILLION)
  • TABLE 118: FRANCE: DIGITAL THERAPEUTICS MARKET SIZE FOR TREATMENT/CARE-BASED APPLICATIONS, 2014-2021 (USD THOUSAND)
  • TABLE 119: FRANCE: DIGITAL THERAPEUTICS MARKET SIZE, BY SALES CHANNEL, 2014-2021 (USD MILLION)
  • TABLE 120: FRANCE: DIGITAL THERAPEUTICS MARKET SIZE FOR B2C SALES CHANNEL, BY BUYER, 2014-2021 (USD MILLION)
  • TABLE 121: FRANCE: DIGITAL THERAPEUTICS MARKET SIZE FOR B2B SALES CHANNEL, BY BUYER, 2014-2021 (USD THOUSAND)
  • TABLE 122: SPAIN: DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 123: SPAIN: DIGITAL THERAPEUTICS MARKET SIZE FOR PREVENTIVE APPLICATIONS, BY DISORDER, 2014-2021 (USD THOUSAND)
  • TABLE 124: SPAIN: DIGITAL THERAPEUTICS MARKET SIZE FOR TREATMENT/CARE-BASED APPLICATIONS, 2014-2021 (USD THOUSAND)
  • TABLE 125: SPAIN: DIGITAL THERAPEUTICS MARKET SIZE, BY SALES CHANNEL, 2014-2021 (USD THOUSAND)
  • TABLE 126: SPAIN: DIGITAL THERAPEUTICS MARKET SIZE FOR B2C SALES CHANNEL, BY BUYER, 2014-2021 (USD THOUSAND)
  • TABLE 127: SPAIN: DIGITAL THERAPEUTICS MARKET SIZE FOR B2B SALES CHANNEL, BY BUYER, 2014-2021 (USD THOUSAND)
  • TABLE 128: ROE: DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 129: ROE: DIGITAL THERAPEUTICS MARKET SIZE FOR PREVENTIVE APPLICATIONS, BY DISORDER, 2014-2021 (USD MILLION)
  • TABLE 130: ROE: DIGITAL THERAPEUTICS MARKET SIZE FOR TREATMENT/CARE-BASED APPLICATIONS, 2014-2021 (USD THOUSAND)
  • TABLE 131: ROE: DIGITAL THERAPEUTICS MARKET SIZE, BY SALES CHANNEL, 2014-2021 (USD THOUSAND)
  • TABLE 132: ROE: DIGITAL THERAPEUTICS MARKET SIZE FOR B2C SALES CHANNEL, BY BUYER, 2014-2021 (USD THOUSAND)
  • TABLE 133: ROE: DIGITAL THERAPEUTICS MARKET SIZE FOR B2B SALES CHANNEL, BY BUYER, 2014-2021 (USD THOUSAND)
  • TABLE 134: APAC: DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 135: APAC: DIGITAL THERAPEUTICS MARKET SIZE FOR PREVENTIVE APPLICATIONS, BY DISORDER, 2014-2021 (USD MILLION)
  • TABLE 136: APAC: DIGITAL THERAPEUTICS MARKET SIZE FOR TREATMENT/CARE-BASED APPLICATIONS, 2014-2021 (USD THOUSAND)
  • TABLE 137: APAC: DIGITAL THERAPEUTICS MARKET SIZE, BY SALES CHANNEL, 2014-2021 (USD MILLION)
  • TABLE 138: APAC: DIGITAL THERAPEUTICS MARKET SIZE FOR B2C SALES CHANNEL, BY BUYER, 2014-2021 (USD MILLION)
  • TABLE 139: APAC: DIGITAL THERAPEUTICS MARKET SIZE FOR B2B SALES CHANNEL, BY BUYER, 2014-2021 (USD THOUSAND)
  • TABLE 140: ROW: DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 141: ROW: DIGITAL THERAPEUTICS MARKET SIZE FOR PREVENTIVE APPLICATIONS, BY DISORDER, 2014-2021 (USD MILLION)
  • TABLE 142: ROW: DIGITAL THERAPEUTICS MARKET SIZE FOR TREATMENT/CARE-BASED APPLICATIONS, 2014-2021 (USD THOUSAND)
  • TABLE 143: ROW: DIGITAL THERAPEUTICS MARKET SIZE, BY SALES CHANNEL, 2014-2021 (USD MILLION)
  • TABLE 144: ROW: DIGITAL THERAPEUTICS MARKET SIZE FOR B2C SALES CHANNEL, BY BUYER, 2014-2021 (USD THOUSAND)
  • TABLE 145: ROW: DIGITAL THERAPEUTICS MARKET SIZE FOR B2B SALES CHANNEL, BY BUYER, 2014-2021 (USD THOUSAND)
  • TABLE 146: PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS, 2016
  • TABLE 147: INVESTMENTS, 2015-2016
  • TABLE 148: NEW PRODUCT LAUNCHES, 2014-2016
  • TABLE 149: OTHER STRATEGIES, 2013-2016

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
  • FIGURE 3: MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
  • FIGURE 4: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: DIGITAL THERAPEUTICS FOR PREVENTIVE APPLICATIONS TO REGISTER HIGH GROWTH DURING THE FORECAST PERIOD
  • FIGURE 7: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, 2016 VS. 2021
  • FIGURE 8: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE APPLICATIONS, 2016 VS. 2021
  • FIGURE 9: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL: B2B SALES CHANNEL EXPECTED TO DOMINATE THE MARKET IN 2016
  • FIGURE 10: CAREGIVERS SEGMENT TO REGISTER SIGNIFICANT GROWTH DURING THE FORECAST PERIOD
  • FIGURE 11: PAYERS TO DOMINATE THE DIGITAL THERAPEUTICS MARKET DURING THE FORECAST PERIOD
  • FIGURE 12: DIGITAL THERAPEUTICS MARKET, BY REGION: NORTH AMERICA IS EXPECTED TO REGISTER THE HIGHEST GROWTH IN THE FORECAST PERIOD
  • FIGURE 13: VENTURE CAPITAL INVESTMENTS AND SUPPORTING GOVERNMENT INITIATIVES: MAJOR FACTORS DRIVING MARKET GROWTH
  • FIGURE 14: SOLUTIONS FOR TREATMENT/CARE SEGMENT TO DOMINATE THE DIGITAL THERAPEUTICS MARKET IN 2016
  • FIGURE 15: OBESITY SEGMENT TO REGISTER HIGHEST GROWTH IN THE FORECAST PERIOD
  • FIGURE 16: DIABETES TO DOMINATE THE MARKET BY 2021
  • FIGURE 17: B2B SEGMENT TO FORM THE LARGEST SALES CHANNEL IN 2016
  • FIGURE 18: CAREGIVERS TO BE THE LARGEST SEGMENT OF THE MARKET IN 2016
  • FIGURE 19: PAYERS TO COMMAND THE LARGEST MARKET SHARE IN 2016
  • FIGURE 20: U.S. TO WITNESS HIGHEST MARKET GROWTH DURING THE FORECAST PERIOD
  • FIGURE 21: DIGITAL THERAPEUTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 22: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 23: DIGITAL THERAPEUTICS MARKET SEGMENTATION, BY SALES CHANNEL
  • FIGURE 24: B2B SEGMENT TO DOMINATE THE DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, IN 2016
  • FIGURE 25: CAREGIVERS TO DOMINATE THE DIGITAL THERAPEUTICS MARKET, BY B2C SALES CHANNEL, IN 2016
  • FIGURE 26: PAYERS TO DOMINATE THE DIGITAL THERAPEUTICS MARKET, BY B2B SALES CHANNEL, IN 2016
  • FIGURE 27: DIGITAL THERAPEUTICS MARKET, BY TYPE OF APPLICATION
  • FIGURE 28: TREATMENT/CARE-RELATED APPLICATIONS TO DOMINATE THE DIGITAL THERAPEUTICS MARKET IN 2016
  • FIGURE 29: OBESITY TO DOMINATE THE DIGITAL THERAPEUTICS APPLICATION MARKET IN 2016
  • FIGURE 30: DIABETES TO DOMINATE THE DIGITAL THERAPEUTICS APPLICATION MARKET IN 2016
  • FIGURE 31: NORTH AMERICA TO DOMINATE THE DIGITAL THERAPEUTICS MARKET IN 2016
  • FIGURE 32: NORTH AMERICA: DIGITAL THERAPEUTICS MARKET OVERVIEW
  • FIGURE 33: KEY PLAYERS ADOPTED ORGANIC AS WELL AS INORGANIC GROWTH STRATEGIES BETWEEN 2013 AND 2016
  • FIGURE 34: MARKET EVOLUTION FRAMEWORK
  • FIGURE 35: BATTLE FOR MARKET SHARE: PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS-THE KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS
  • FIGURE 36: PRODUCT PORTFOLIO MIX FOR THE TOP 5 PLAYERS
Back to Top